100
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Users’ perspectives on Implanon in Malaysia, a multicultural Asian country

, &
Pages 79-84 | Published online: 15 Feb 2011

References

  • Affandi B, Korver T, Geurts TB, Coelingh Bennink HJ. A pilot efficacy study with a single-rod contraceptive implant (Implanon) in 200 Indonesian women treated for <4 years. Contraception. 1999;59:167–74. Retraction in: Rekers H, Affandi B. Contraception. 2004;70:433.
  • Biswas A, Biswas S, Viegas OA. Effect of etonogestrel subdermal contraceptive implant (Implanon) on liver function tests – a randomized comparative study with Norplant implants. Contraception. 2004;70(5):379–382.
  • Funk S, Miller MM, Mishell DR Jr, Archer DF, Poindexter A, et al. Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception. 2005;71:319–326.
  • Glasier A. Implantable contraceptives for women: Effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies. Contraception. 2002;65:29–37.
  • Mascarenhas L. Insertion and removal of Implanon. Contraception. 1998;58:79S–83S.
  • Belsey EM, Farley TMM. The analysis of menstrual bleeding patterns: A review. Contraception. 1988;38:129–156.
  • Booranabunyat S, Taneepanichskul S. Implanon use in Thai women above the age of 35 years. Contraception. 2004;69:489–491.
  • Affandi B. An integrated analysis of vaginal bleeding patterns in clinical trials of Implanon. Contraception. 1998;58:99S–107S.
  • National Collaborating Centre for Women’s and Children’s Health. Long-acting reversible contraception: The effective and appropriate use of long-acting reversible contraception. London, UK: RCOG Press; 2005. Available at: http://www.nice.org.uk/CG030. Accessed 26 March, 2010.
  • Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception. 1999;60:1–8.
  • Harvey C, Seib C, Lucke J. Continuation rates and reasons for removal among Implanon® users accessing two family planning clinics in Queensland, Australia. Contraception. 2009;80:527–532. Available from: http://www.contraceptionjournal.org/article/S0010- 7824(09)00300-X/abstract. Accessed March 26, 2010.
  • Urbancsek J. An integrated analysis of nonmenstrual adverse events with Implanon. Contraception. 1998;58:109S–115S.
  • Brachea V Faundes A, Alvareza F, Cochona L. Nonmenstrual adverse events during use of implantable contraceptives for women: Data from clinical trials. Contraception. 2002;65:63–74.
  • Diaz S. Contraceptive implants and lactation. Contraception. 2002;65:39–46.
  • Reinprayoon D, Taneepanichskul S, Bunyavejchevin S, et al. Effects of the etonogestrel-releasing contraceptive implant (Implanon®) on parameters of breastfeeding compared to those of an intrauterine device. Contraception. 2000;62:239–246.
  • Herjan JT, Coelingh Bennink HJ. Presentation of clinical data on Implanon. Contraception. 1998;58:75S–77S.
  • Affandi B. Long-acting progestogens. Best practice and research. Clin Obstet Gynaecol. 2002;16:169–179.
  • Croxatto HB. Progestin implants. Steroids. 2000;65:681–685.